Edward Nash analyst CANACCORD

Currently out of the existing stock ratings of Edward Nash, 122 are a BUY (90.37%), 12 are a HOLD (8.89%), 1 are a SELL (0.74%).

Edward Nash

Work Performance Price Targets & Ratings Chart

Analyst Edward Nash works at CANACCORD with a stock forecast success ratio of 45.69% fulfilled within 239.47 days on average. Previously, Edward Nash worked at TRUIST.

Edward Nash’s has documented 274 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CORT, Corcept Therapeutics orporated at 13-Dec-2023.

Wall Street Analyst Edward Nash

Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 6/6/2017. The price target of $69.95 was fulfilled within 1 day with a profit of $6.38 (10.04%) receiving and performance score of 100.36.

Average potential price target upside

AKAO Achaogen AKRO Akero Therapeutics BLUE Bluebird bio CRDL Cardiol Therapeutics GLMD Galmed Pharmaceuticals Ltd ICPT Intercept Pharmaceuticals MDGL Madrigal Pharmaceuticals MTCR Metacrine  ORMP Oramed Pharmaceuticals SRPT Sarepta Therapeutics THTX Theratechnologies . VRNA Verona Pharma PLC ADR ITCI Intracellular Th ONCE Spark Therapeutics RARE Ultragenyx TVTX Travere Therapeutics BMRN Biomarin Pharmaceutical CCXI ChemoCentryx DRNA Dicerna Pharmaceuticals OBSV ObsEva SA OTIC Otonomy TTPH Tetraphase Pharmaceuticals CPRX Catalyst Pharmaceuticals SAGE Sage Therapeutic VTYX Ventyx Biosciences AMYT Amryt Pharma Holdings Ltd ABEO Abeona Therapeutics ZFGN Zafgen CORT Corcept Therapeutics orporated DICE Dice Molecules Holdings LLC

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

3

$2.89 (2627.27%)

10

5 years 3 months 16 days ago

0/5 (0%)

$1.07 (55.44%)

Hold

3

$2.89 (2627.27%)

19

5 years 3 months 17 days ago

0/5 (0%)

$1 (50.00%)

Hold

5 years 3 months 20 days ago

1/4 (25%)

$8.57 (47.07%)

31

Hold

8

$7.89 (7172.73%)

20

5 years 3 months 23 days ago

1/5 (20%)

$4.75 (146.15%)

41

Buy

22

$21.89 (19900.00%)

28

6 years 15 days ago

1/3 (33.33%)

$11.09 (101.65%)

22

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Edward Nash is most bullish on?

Potential upside of $14.3 has been obtained for CORT (CORCEPT THERAPEUTICS ORPORATED)

Which stock is Edward Nash is most reserved on?

Potential downside of -$0 has been obtained for ICPT (INTERCEPT PHARMACEUTICALS)

What Year was the first public recommendation made by Edward Nash?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?